Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Early detection and treatment of COPD are becoming important for improving the prognosis of individuals who have a history of heavy tobacco use. Despite the higher risk of COPD among individuals participating in lung cancer screening, many of these patients continue to show rates of underdiagnosis of lung cancer.
Research Question: How many participants in lung cancer screening have emphysema or airflow limitation? If spirometry is incorporated into the screening, how many additional patients with airflow limitation could be identified?
Study Design And Methods: The Ovid-MEDLINE and Embase databases were searched from inception through November 30, 2023. We included original studies reporting the prevalence of CT scan-confirmed emphysema and spirometry-confirmed airflow limitation. The primary outcomes were the prevalence of emphysema and airflow limitation. For studies reporting severity, we analyzed the percentage of mild vs moderate to severe disease. We also calculated the proportion of newly confirmed cases of airflow limitation via spirometry.
Results: In total, 42 studies were included (emphysema, n = 18; airflow limitation, n = 13; both, n = 11), comprising 126,842 individuals with emphysema and 72,209 individuals with airflow limitation. The pooled prevalence of emphysema was 45.3% (95% CI, 39.3%-51.2%), and that of airflow limitation was 40.1% (95% CI, 33.4%-46.8%). Moderate to severe emphysema was observed in 28.8% of patients with emphysema (95% CI, 24.2%-33.4%), whereas 54.3% patients with airflow limiation (95% CI, 40.6%-60.6%) showed moderate to very severe airflow limitation. Furthermore, 65.2% of patients with airflow limitation (95% CI, 55.7%-74.7%) identified by spirometry had been unrecognized previously.
Interpretation: Among screening participants, 45.3% demonstrated emphysema and 40.1% demonstrated airflow limitation, with 28.8% and 54.3% of these patients showing moderate to severe disease, respectively. Furthermore, 65% of patients with airflow limitation had not received a diagnosis previously. These findings suggest that incorporating spirometry into screening programs may enhance COPD detection and management.
Clinical Trial Registry: International Prospective Register of Systematic Reviews; No.: CRD42024513248; URL: https://www.crd.york.ac.uk/prospero/.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chest.2025.02.021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prognostic Value of Biomarkers in Chronic Obstructive Pulmonary Disease: A Comprehensive Review.
Int J Chron Obstruct Pulmon Dis
September 2025
The First Clinical Medical College of Lanzhou University, Lanzhou, People's Republic of China.
Chronic Obstructive Pulmonary Disease (COPD) is a prevalent chronic respiratory disorder characterized by airway inflammation and irreversible airflow limitation. Its marked heterogeneity and complexity pose significant challenges to traditional clinical assessments in terms of prognostic prediction and personalized management. In recent years, the exploration of biomarkers has opened new avenues for the precise evaluation of COPD, particularly through multi-biomarker prediction models and integrative multimodal data strategies, which have substantially improved the accuracy and reliability of prognostic assessments.
View Article and Find Full Text PDFThe utility of spirometry and single breath gas transfer measurements to identify low total lung capacity.
ERJ Open Res
September 2025
Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Background: Measurement of total lung capacity (TLC) requires large and expensive equipment. We aimed to investigate whether spirometric restriction and low alveolar volume measured by single breath gas transfer ( ) can be used to identify those with a low TLC.
Methods: We retrospectively analysed data from adults referred to Cambridge University Hospitals between January 2016 and December 2023.
Preserved ratio impaired spirometry, dysanapsis and airflow obstruction with low forced expiratory volume in 1 s in childhood asthma.
ERJ Open Res
September 2025
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Background: Airway obstruction is a characteristic spirometric finding in asthma but the clinical significance of other abnormal spirometric patterns is less well described. We aimed to explore pre- and post-bronchodilator (BD) prevalences and clinical characteristics of preserved ratio impaired spirometry (PRISm), dysanapsis and airflow obstruction with low forced expiratory volume in 1 s (FEV) in children diagnosed with asthma.
Methods: We extracted specialist care data (clinical and spirometry) from the Swedish National Airway Register (n=3301, age 5-17 years).
Clinical Characteristics of Individuals with COPD, Pre-COPD, Smokers with Normal Lung Function in Korea: Updated Analysis of the KOCOSS Cohort.
Tuberc Respir Dis (Seoul)
September 2025
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Korea.
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung disease characterized by persistent airflow limitation and is a leading cause of mortality worldwide. Pre-COPD refers to a pre-disease state associated with an increased risk of COPD development. This study aims to evaluate the clinical characteristics of individuals with COPD, pre-COPD, and smokers with normal lung function in South Korea, and to provide an updated analysis of the KOCOSS cohort data.
View Article and Find Full Text PDFRisk factors for Progression to Frequent Exacerbators in Stable Patients with COPD.
Tuberc Respir Dis (Seoul)
September 2025
Division of Pulmonary and Allergy, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Korea.
Background: Little is known about the transition to frequent exacerbators in stabilized patients with chronic obstructive pulmonary disease (COPD).
Methods: This study utilized data obtained from the Korean COPD subgroup study cohort (KOCOSS), including 511 patients with infrequent exacerbations. The outcome for these groups was progression to frequent exacerbators.